StonvexLoading…
StonvexStonvexStonvexCore line items from XPOF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $66.03M | $60.71M | $314.88M | $231.91M | $153.09M |
Operating Income | Not available | $13.04M | $19.85M | $28.07M | $24.50M |
Net Income | Not available | $-725.00K | $-38.68M | $-5.81M | $-954.00K |
EPS (Diluted) | $0.10 | $-0.02 | $-1.47 | $-0.28 | $-0.11 |
Total Assets | Not available | $322.40M | $345.63M | $355.30M | $399.81M |
Total Liabilities | Not available | $694.38M | $717.59M | $559.00M | $596.17M |
Cash & Equivalents | Not available | $21.47M | $45.86M | $41.46M | $38.68M |
Free Cash Flow OCF − CapEx | Not available | $-22.15M | $24.74M | $14.57M | $6.35M |
Shares Outstanding | Not available | 37.32M | 34.80M | 34.67M | 34.44M |